Table 1.
Cases | Controls | p | |||
---|---|---|---|---|---|
Male | Female | Male | Female | ||
Sex | 12 | 10 | 20 | 24 | |
Type of CHD | |||||
ASD | 5 | 2 | 0 | 0 | |
VSD | 10 | 5 | 0 | 0 | |
Weeks of gestation | |||||
<37 | 4 | 4 | 1 | 4 | 0.0122 |
38–41 | 10 | 4 | 19 | 20 | |
>42 | 0 | 0 | 0 | 0 | |
Weight | |||||
<2500 g | 2 | 3 | 0 | 0 | 0.023 |
2500–3500 g | 10 | 3 | 14 | 21 | |
>3500 g | 2 | 2 | 6 | 3 | |
Height | |||||
<48 cm | 6 | 6 | 2 | 1 | 0.0001 |
48–50 cm | 4 | 0 | 8 | 14 | |
>50 cm | 4 | 2 | 10 | 9 | |
Maternal folic acid intake | |||||
Preconceptional | 0 | 3 | 0 | 0 | 0.0071 |
During pregnancy | 10 | 7 | 20 | 24 | |
None | 2 | 0 | 0 | 0 | |
Origin | Northeastern Mexico |
For the variables weeks of gestation, weight, and height, all with a normal distribution, p values were obtained using an unpaired student’s t test. For folic acid intake, the p value was obtained using chi-square analysis. P.05 statistical analysis was performed with GraphPad Prism v.8 software.